Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...

Bone regeneration research has taken a significant leap forward with the discovery of a crucial mechanism that could ...

Neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system. The new study provides the most detailed mapping of ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

Huang, B.T., Li, K.F., Wu, X.S., Zhang, F.Y. and Li, Y.P. (2025) Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer. Journal of Biosciences and Medicines, ...

Real-time observation of certain biochemical processes in blood vessels from mice has revealed a previously unknown ...

Moritz Lehners, Hannes Schmidt, Maria T K Zaldivia, Daniel Stehle, Michael Krämer, Andreas Peter, Julia Adler, Robert Lukowski, Susanne Feil, Robert Feil: Single-cell analysis identifies the ...

Scientists uncover how Ffar4 regulates sugar cravings through gut microbiota, revealing pantothenate as a key mediator to ...

Syn-Coll, a synthetic tripeptide derived from the collagen sequence, has garnered attention in scientific research for its hypothesized potential to influence processes associated with extracellular ...

Clinical-stage CAR T company dosed first patient for Phase 1 trial to evaluate SynKIR™-310, a new drug candidate for relapsed/refractory B cell Non-Hodgkin ...

Verismo Therapeutics, a clinical-stage CAR T company developing novel KIR-CAR platform technology, today announced that it has dosed the first patient in its CELESTIAL-301 Phase 1 clinical trial. The ...